Boston Scientific Corp. (BSX) - Get Report is expected to report net income of $535 million, or 38 cents a share, on sales of $2.6 billion before the market opens on Wednesday, based on a FactSet survey of 22 analysts.
In the same period a year ago, the company posted earnings of 41 cents a share on sales of $2.5 billion. It reported net income of $298 million.
The company offered guidance of 37 cents a share to 39 cents a share at the time of its last earnings report on April 24. Shares have risen 19.2% since then.
Quarterly estimates have risen less than 1 cent a share in the past month.
Boston Scientific is currently trading at a price-to-forward-earnings ratio of 25.3 based on the 12-month estimates of 23 analysts surveyed by FactSet.
In the upcoming quarter analysts are forecasting net income of $554.3 million, or 39 cents a share, on sales of $2.6 billion.
Jim Cramer and the Action Alerts Plus team are watching the Health Care Equipment & Supplies sector. To find out more about what stocks they like in the industry click here now to get more from Action Alerts PLUS.
Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.